Analysis Group

Analysis Group provides economic, financial, and business strategy consulting to law firms, corporations across multiple industries, and government agencies.

[Analysis Group @analysisgroup]

AG researchers coinvestigated real-world outcomes related to cilta-cel as a treatment for patients with RRMM after 1–3 prior lines of therapy. Further research may help contextualize cilta-cel’s potential as a functional cure. https://t.co/MLFzk39NMN

[Analysis Group @analysisgroup]

The District Court of Amsterdam relied on testimony from Principal Chris Feige in its dismissal of damages claims against Vestolit in two matters related to a European Commission infringement involving ethylene purchasers. https://t.co/q9RHjjVYqO

[Analysis Group @analysisgroup]

In Health Affairs Scholar, Analysis Group authors share new research on how investors responded to the Trump administration’s previously announced most-favored nation drug pricing agreements. https://t.co/gKSgTvIJ0j

[Analysis Group @analysisgroup]

Managing Principal Joshua White and Principal Jessica Resch share how expert “hot-tubbing” can shape how expert evidence is presented, tested, and understood. https://t.co/g7KqyfU5Kl

[Analysis Group @analysisgroup]

Those pursuing equitable outcomes must consider challenges associated with equitable medication access, or pharmacoequity. AG affiliate Laura Happe outlines a framework to assess progress toward pharmacoequity, across demographic and socioeconomic divides. https://t.co/nR0Ij487K5

[Analysis Group @analysisgroup]

AG competition experts submitted comments in response to the Israel Competition Authority’s call for input on its Draft Merger Guidelines. The authors welcomed the expanded treatment around some issues while recommending greater transparency around others. https://t.co/FJPi4cELZb

[Analysis Group @analysisgroup]

Vice President Erica VanSant will join a panel on Most Favored Nation drug pricing and its implications for global pharmaceutical markets at ACI’s Summit for Women Leaders in Life Sciences Law. https://t.co/tvhLdjyitM

[Analysis Group @analysisgroup]

At GCR Live Europe in Brussels, Managing Principal Aditi Mehta and Competition Expert Pierre Régibeau drew on their significant regulatory experience to provide insights on the current and future landscapes of antitrust enforcement in the US and Europe. https://t.co/qKD46FHEk1

[Analysis Group @analysisgroup]

For an article published on the American Bar Association Antitrust Law Section website, Managing Principal Andrea Okie summarized an ABA Spring Meeting panel on competition policy and regulation in the US economy. https://t.co/lizpggPlYL

[Analysis Group @analysisgroup]

AG was pleased to host clients and friends for a reception overlooking the Tall Ships Festival and fireworks. The evening offered a wonderful opportunity to connect with valued local clients and contacts while enjoying this historic festival.

[Analysis Group @analysisgroup]

Vice President Anne Catherine Faye examines how the FTC is adapting its financial deception enforcement strategy post-AMG Capital, including its focus on earnings claims, MLMs, AI-related business opportunities, and gig-economy compensation. https://t.co/pSI9opillF

[Analysis Group @analysisgroup]

Affiliate Christopher Armstrong, Vice President Carlo Gallimberti, and Manager David Tsui discuss the rise in private credit defaults and an underappreciated signal of borrower risk in Law360. https://t.co/nH3tklZ5oF

[Analysis Group @analysisgroup]

AG competition experts responded to the European Commission's call for input on its Draft Merger Guidelines. Their report offers recommendations to support a more comprehensive, balanced, and modern framework for merger assessment in Europe. https://t.co/kzQMdbzvKH

[Analysis Group @analysisgroup]

Analysis Group Managing Principal Noam Kirson and affiliate Professor John Cawley will serve as guest editors of a forthcoming issue of PharmacoEconomics on obesity and GLP-1 treatments. Abstract submissions are welcome until September 30. https://t.co/HdFbPiwJzg

[Analysis Group @analysisgroup]

Vice President Olga Kozlova Guglielmi will moderate an ABA Antitrust Law Section Diverse Perspectives & Engagement Town Hall on recent European resale price maintenance enforcement cases across industries. https://t.co/u9tr75kwzt

[Analysis Group @analysisgroup]

Manager Cecilia Caliandro will participate in an ABA Antitrust Law Section webinar on the European Commission’s recently published draft merger guidelines, discussing the proposed EU merger review framework from an economist’s perspective. https://t.co/TUsmtAcmQD

[Analysis Group @analysisgroup]

Marketing professor and Analysis Group affiliate Alixandra Barasch discusses how marketing methods can help us understand the impact of algorithmic pricing, AI-based customer service, and other new technologies on consumer perceptions and behavior. https://t.co/pMsYHHivzV

[Analysis Group @analysisgroup]

As the MDPNP expands to include Part B drugs, manufacturers face increasing pressure to demonstrate treatment value. In an AG feature, consultants discuss how RWE can support value assessments, strengthen ICR responses, and prepare for CMS negotiations. https://t.co/M2QI2vtLyQ

[Analysis Group @analysisgroup]

Managing Principal Antoine Chapsal will moderate the closing discussion at Concurrences’ Global Merger Control Conference in Paris, bringing an economic perspective to evolving merger policy and competition analysis. https://t.co/r74h6OLL6R

[Analysis Group @analysisgroup]

Analysis Group is pleased to sponsor tonight's reception during the 2026 Western Finance Association Annual Meeting. We look forward to connecting with leading scholars at the conference.

More information about the conference: https://t.co/CCf8ZKzXXs